Deciphera Pharmaceuticals, LLC – Trademark Portfolio

Entity Type: 16

Deciphera Pharmaceuticals, LLC holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 7 Nice Classification classes. Currently, 7 trademarks are registered and 9 are pending. Notable registered marks include QINLOCK, ROMVIMZA, DECIPHERA, and ONE MISSION, INSPIRED BY PATIENTS: DEFEAT CANCER.. The owner is based in Waltham, MA.